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Abstract
Background: α1-Antitrypsin deficiency (AATD) is an auto-
somal codominant disorder associated with a high risk 
of developing lung and liver disease. The most common 
deficient alleles are known as Z and S. However, another 
deficient variant, called Mmalton, which causes a defi-
ciency similar to variant Z, is considered to be the second 
cause of severe AATD in Spain. Nevertheless, the Mmalton 
allele is not recognizable by usual diagnostic techniques 
and therefore, its real prevalence is underestimated. We 
describe a rapid real-time PCR and melting curves assay 
designed for the detection of Mmalton AATD.
Methods: We tested the applicability of this new tech-
nique for the identification of the Mmalton allele in AATD 
screening using whole blood, dried blood spot (DBS) and 
serum samples. Mmalton heterozygote and homozygote 
samples and samples without this allele were included in 
the study.
Results: This new assay is able to detect homozygous and 
heterozygous genotypes in the same reaction and in a 
single step, giving matching results with those obtained 
by SERPINA1 gene sequencing.
Conclusions: This technology is optimal for working 
with small amounts of DNA, such as in DBS and even 
with residual DNA present in serum samples, allowing 
improvement in routine algorithms of AATD diagnosis 
or large-scale screening. This method will be useful for 
obtaining more in depth knowledge of the real incidence 
of the Mmalton variant.
Keywords: α1-antitrypsin deficiency; dried blood spot; 
FRET probes; melting curves; Mmalton variant.
Introduction
Human α1-antitrypsin (AAT) is a member of the Serpin 
(Serin Proteases Inhibitor) superfamily and is a secre-
tory protein mainly produced by the liver, being the most 
abundant circulating serum antiprotease [1]. AAT, also 
known as α1 protease inhibitor (α1-PI), shows a broad 
spectrum of antiserine-protease activities, including 
the inhibition of free elastase from neutrophils, but also 
has antioxidant, anti-inflammatory, anti-infectious and 
immunomodulation effects [2, 3]. AAT is encoded by 
the SERPINA1 gene (PI locus: 14q32.1) which is organ-
ized into three non-encoding exons (1A, 1B and 1C) and 
four encoding exons (2–5) [4]. Despite its small size 
(394 amino-acid), AAT is a highly polymorphic protein 
with over 120 variants, including at least 60 deficiency 
alleles [5]. α-1-antitrypsin deficiency (AATD) is a heredi-
tary autosomal disorder characterized by low circulating 
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AAT levels 35% (or 0.5 g/L) below the normal value as 
the consequence of mutations in the SERPINA1 gene. 
These mutations are associated with the misfolding 
of AAT molecules promoting the production of intra-
hepatic AAT polymers which can cause cell stress and 
liver damage [6]. Moreover, as a result of polymerization/
retention into hepatocytes, the concentration of AAT 
in blood and tissues is reduced, being associated with 
lung tissue damage and emphysema due to uncontrolled 
elastase activity [5].
Normal alleles are most commonly M subtypes, 
which account for 95% of the gene variants. The most 
common deficient alleles are PI S (rs17580: c.863A > T; 
p.Glu264Val), with a prevalence of 5%–10% in Cauca-
sians and PI Z (rs28929474; c.1096G > A; p.Glu342Lys), 
with a prevalence of 1%–3% [7]. PI S and PI Z alleles are 
associated with reduced serum levels of AAT of up to 40% 
and 10%–20%, respectively. Therefore, the PI Z allele is 
related to severe deficiency and is the phenotype most 
often associated with lung and liver disease [8]. More 
than 95% of individuals with severe deficiency have the 
PI ZZ genotype. Non-S and non-Z deficient variants are 
called “rare” because of their low frequency. In a retro-
spective review of AATD studies performed in our labo-
ratory, a remarkably high frequency of the deficient PI I 
and PI Mmalton alleles was observed, together account-
ing for 54% of all rare AAT variants in Spain (34% for 
PI I and 20% for PI Mmalton) [9]. While the PI I variant 
causes moderate AATD (60%–70% of normal level), from 
a clinical point of view, the PI Mmalton variant mimics 
the PI Z clinical phenotype [10]. This last mutation has 
been detected in many countries [9]. For example, in 
Central and Southern Italy (particularly in Sardinia), the 
PI Mmalton and the PI Mprocida (Leu41Pro) variants are 
more prevalent than PI Z [10]. The PI Mmalton variant 
consists of the deletion of an entire TTC codon in exon II, 
and subsequent deletion of the Phe51 or Phe52 residue of 
the mature protein [11].
The current approach to laboratory diagnosis of AATD 
involves the use of a combination of serum AAT measure-
ment and phenotype characterization by isoelectric focus-
ing (IEF) or the usual allele-specific genotyping assay 
included in large-scale screening programs for detecting 
PI S and PI Z alleles [12]. Nevertheless, most rare variants 
are difficult or even impossible to detect with the above 
methods, which may have contributed to a misclassifica-
tion of many of these cases, with the subsequent underes-
timation of their true frequency. Most of these alleles can 
only be detected by molecular biology techniques, such 
as exonic sequencing of SERPINA1 gene, which is not 
available in all routine laboratories [13]. In this sense, PI 
Mmalton is characterized by a normal isoelectrophoretic 
pattern (M-Like variant) [14]. Thus, the characterization 
of this variant as part of routine laboratory algorithms for 
AATD diagnosis is not possible using an isoelectropho-
retic pattern, making application of molecular methods 
for the identification of this variant, such as Southern blot 
hybridization [11], denaturing gradient gel electrophoresis 
[15], DNA haplotypes [16] and SERPINA1 sequencing man-
datory. Nonetheless, this methodology is time consuming 
and requires multiple manual steps and is not available 
in most routine laboratories. Therefore, a more suitable, 
rapid, and sensitive method is necessary to obtain in 
depth knowledge of the real incidence and impact of this 
variant in AATD.
In this paper we describe the design of specific 
 fluorescence resonance energy transfer (FRET) probes 
for the detection of the PI Mmalton variant by real-time 
PCR and melting curves analysis using the LightCycler 
analyzer. This technique allows DNA amplification and 
simultaneous detection and documentation of genetic 
polymorphisms. We tested its applicability for the iden-
tification of the PI Mmalton allele in AATD screening 
with dried blood samples (DBS). In addition, we deter-
mined its possible utility in the molecular detection of 
this variant in residual DNA of serum samples used for 
AAT levels quantification and the IEF technique, which 




Individuals with severe AATD were recruited from the departments 
of Biochemistry and Pneumology of the Vall d’Hebron University 
Hospital (Barcelona, Spain). The study was approved by the Ethi-
cal Committee Board and informed consent was obtained from all 
patients for the genetic analyses. The study was conducted in accord-
ance with the principles of the Declaration of Helsinki, Guidelines 
for Good Clinical Practice and in full conformity with relevant regula-
tions.
For the design of the technique, EDTA (ethylenediaminetet-
raacetate) whole blood and DBS samples were obtained from three 
related individuals characterized by IEF as MM, MS and MZ, but with 
clearly low serum AAT levels: 0.75, 0.45 and 0.32 g/L, respectively. In 
the three cases the determination of the AAT genotype was carried 
out with an exonic sequencing of SERPINA1 gene in DNA isolated 
from whole blood as described below.
DNA sequence analysis showed that three individuals were het-
erozygous for the PI Mmalton allele (Mmalton/M, Mmalton/S and 
Mmalton/Z, respectively), which had previously been wrongly char-
acterized as a normal M allele.
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In addition, we used 10 DBS and whole blood samples from 
individuals with an AAT genotype with alleles different from the PI 
Mmalton variant (M/M, M/S, M/Z, S/Z, S/S, Z/Z, M/Null Mattawa, 
M/I, M/Plowel and M/Mvalld’hebron) as specificity controls of the 
new technique.
All DBS samples processed in this study were spotted from 
whole blood samples obtained by venopuncture. The drops of blood 
were applied to the AlphaKit/DBS filter paper (Grifols, Barcelona, 
Spain) which were then left to dry at room temperature.
DNA extraction
DNA extraction from EDTA whole blood and serum samples were per-
formed using the QIAamp DNA Mini Kit (Qiagen, Hilden,  Germany) 
and DNA from DBS was obtained using a previously described 
 protocol [17].
Exonic sequencing of SERPINA1 gene
This method consists of the amplification of DNA extracted by PCR 
followed by Sanger automated sequencing of the PCR products. This 
determination requires a complete study of the DNA sequences of the 
four encoding exons of the SERPINA1 gene. We used the same prim-
ers for both PCR and sequencing methods and these are shown in 
Table 1 (GeneBank accession n.K02212).
Obtaining homozygous PI Mmalton
To obtain a positive control for genotyping with real-time PCR and 
melting curves, molecular cloning was performed from a sample 
of EDTA whole blood corresponding to a Mmalton/M heterozygote 
individual, previously characterized by SERPINA1 sequencing. A 
fragment of 450 bp of the second AAT exon (nucleotide 7251-7700) 
was amplified by PCR and cloned using the Zero Blunt TOPO PCR 
Cloning Kit (Invitrogen, Carlsbad, CA, USA). The clones obtained 
were sequenced following the same procedure as that used with 
clinical samples. The nucleotide numbering corresponds to the 
human AAT gene sequence obtained from the Gene Bank (Acces-
sion no. K02212).
Design of the primers and FRET probes
SERPINA1 genotyping was performed in the LightCycler 2.0 analyzer 
(Roche Diagnostic, Mannheim, Germany), which achieves rapid real-
time PCR. This thermal cycler detects mutations by analysis of the 
melting point of one of the two adjacent fluorescently labeled probes.
A schematic representation of oligonucleotide primers, FRET 
probes and the sequence used for genotyping the PI Mmalton allele 
is shown in Figure 1. Primers were designed to flank a region of 171 
bp of the second SERPINA1 gene exon: Serpina 1S: 5′-TTCAACAA-
GATCACCCCCAACC-3′ (nucleotide 7454-7475) and Serpina 1A: 5′-GCC-
CTCCAGGATTTCATCGTG-3′ (nucleotide 7604-7624). FRET probes 
Table 1: Primers sequence, position and annealing temperature for PCR and exonic sequencing of SERPINA1 gene. 
Exon  Sequence   Position  Annealing 
temperature, °C
2   18Fw: 5′ GATCACTGGGAGTCATCATGTGC 3′   7251-7273  54
  18Rv: 5′ GGTTGAGGGTACGGAGGAGT 3′   7681-7700 
  19Fw: 5′CCAAGGCTGACACTCACGAT 3′   7590-7609 
  19Rv: 5′AGGAGAGTTCAAGAACTGATGGTT 3′   8021-8044 
3   3Fw: 5′ TTCCAAACCTTCACTCACCCCTGGT 3′   9362-9386  60
  3Rv: 5′ CGAGACCTTTACCTCCTCACCCTGG 3′   9889-9913 
4   4Fw: 5′ CCCAGAAGAACAAGAGGAATGCTGT 3′  10882-10906  54
  4Rv: 5′ CATTCTTCCCTACAGATACCATGGT 3′   11114-11138 
5   5Fw: 5′ TGTCCACGTGAGCCTTGCTCGAGGC 3′   11841-11865  54
  5Rv: 5′ GACCAGCTCAACCCTTCTTTAATGT 3′   12155-12179 
Figure 1: Representation of sequence, primers and FRET probes employed in this study.
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hybridize very close together and were: Anchor: 5′-AGCTGGCACAC-
CAGTCCAACAGC-3′ (nucleotide 7506-7528) labeled with fluorescein 
at the 3′ end and Sensor Del: 5′-CCAATATCTTCTCCCCAGTGAG-3′ 
(nucleotide 7530-7554) labeled at the 5′ end with red fluorophore 
LC640. This last probe hybridizes over the mutation position and 
matches perfectly with the mutated sequence (deletion of an entire 
TTC codon). The theoretical melting temperatures of the primers 
and probes (Tms), possible oligonucleotide dimers formation, and 
self-complementarity, were calculated using the Oligo Analyzer 3.1 
(Integrated DNA Technologies).
Real-time PCR conditions
The reaction was conducted at a final volume of 20 μL containing 
2 mM MgCl2, 0.5 μM of each primer, 0.2 μM of each FRET probe, 2 μL 
of LightCycler Fast Start DNA Master Hybridization probe mix (Roche 
Diagnostics, Mannheim, Germany) and 5 μL of genomic DNA. The 
PCR program was run as follows: an initial denaturation step of 
95 °C for 10 min, 45 cycles of denaturation at 95 °C for 5 s, anneal-
ing at 54 °C for 10 s and extension at 72 °C for 15 s. After amplifica-
tion, melting curves were generated by denaturation at 95 °C for 20 s, 
maintaining the sample at 40 °C for 20 s and slow heating the sam-
ple at 85 °C. Fluorescent measurements were recorded during each 
annealing step and continuously during the heating of melting step. 
Fluorescence was measured at a wavelength of 640 nm.
LightCycler software converts melting curves into melting peaks 
which allows both normal and mutated alleles to be easily distin-
guished by melting temperatures.
New diagnostic algorithm
Following its design and evaluation, this technology was included 
in the diagnostic algorithm of AATD (Figure 2), as follows: AAT lev-
els were determined, and in cases with concentrations  < 1.2 g/L, the 
phenotype was determined by IEF. If AAT values were in accordance 
with the phenotype observed, the laboratory results were considered 
definitive [13]. However, if AAT levels did not correspond with the 
phenotype, the AAT genotype was determined by an allele-specific 
genotyping assay for the S and Z variants, the new real-time PCR 
technique for detection of the PI Mmalton allele and exonic sequenc-
ing of SERPINA1.
During a period of 6 months, 12 patients with a normal (MM) 
phenotype but with low AAT levels were analyzed by SERPINA1 gene 
sequencing (DNA samples obtained from EDTA whole blood) and the 
new real-time PCR technique (DNA samples obtained from serum, 
DBS and EDTA whole blood).
Figure 2: Proposed AATD diagnostic algorithm.
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Results
Processing of clinical samples
In the case of the three related individuals with a PI 
Mmalton allele (Mmalton/M, Mmalton/S and Mmalton/Z), 
comparative sequencing analysis showed total concord-
ance between genotyping results obtained with this new 
real-time PCR assay and the encoding exons sequenc-
ing method using DBS and EDTA whole blood samples. 
In the melting curves analysis, the three individuals 
showed both 50 °C and 62 °C melting peaks (all samples 
were Mmalton heterozygous). There was also complete 
concordance between the results of both SERPINA1 gene 
sequencing and real-time PCR using 10 DBS and whole 
blood control samples without the PI Mmalton allele. All 
samples showed a single melting peak at 50 °C.
Molecular cloning
We obtained 20 clones which were characterized by 
exonic sequencing of SERPINA1 gene: seven clones were 
PI Mmalton homozygous and 13 clones did not have this 
variant (normal variant). All the clones were analyzed by 
the new real-time PCR and melting curves technique. After 
melting curve analysis, the 13 clones with normal alleles 
showed a melting peak at 50 °C, while the seven clones 
with a mutated PI Mmalton allele showed a melting peak 
at 62 °C. The original sample genotyping (heterozygous) 
showed peaks at 50 °C and 62 °C (Figure 3). These three pat-
terns were confirmed by sequencing (Figure 4). Hence, the 
peak at 62 °C indicates the presence of the PI Mmalton allele 
and the peak at 50 °C indicates the absence of this allele.
Implementation of the diagnostics algorithm
Real-time PCR and melting curves methodology for detect-
ing the PI Mmalton variant was included in the diagnostic 
algorithm of AATD (Figure 2). During the 6-month study 
period, we detected 12 patients with the MM phenotype 
and low AAT levels. Samples obtained from serum, DBS 
and EDTA whole blood were analyzed by the new real-
time PCR technique, and we detected five Mmalton het-
erozygous individuals (showing peaks at both 50 °C and 
62 °C). The genotypes of the remaining seven samples 
were M/M, M/Mvalld’hebron and M/Null Mattawa. The 
results were identical for the three types of samples, with 
total concordance between this new technique and exonic 
sequencing method. Patients’ AAT levels, phenotype, 
sequencing analysis and melting curves output of all the 
patients are shown in Table 2.
Discussion
Our results have shown that the new technique for the 
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Figure 3: Melting peaks obtained by real-time PCR containing the different PI Mmalton genotype profiles.
(A) Homozygous mutated sample, (B) heterozygous, (C) wild type sample.
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interpret and reproducible. Therefore, the implementation 
of this method in our diagnostic algorithm may contribute to 
the detection of new cases of this important deficient allele.
Table 2: Patients’ AAT levels, phenotype, sequencing analysis and 
melting curves results. 
Case 
no.
  AAT levels, 
g/L
  Phenotype  Sequence analysis  Melting 
curves
1   1.00  M/M   M/M   N
2   0.86  M/M   M/M   N
3   0.77  M/M   M/M   N
4   0.72  M/M   M/Null Mattawa   N
5   0.71  M/M   M/Mmalton   H
6   0.86  M/M   M/M   N
7   0.89  M/M   M/Mmalton   H
8   0.87  M/M   M/Mmalton   H
9   0.94  M/M   M/Mvalld’hebron   N
10   0.64  M/M   M/M   N
11   0.72  M/M   M/Mmalton   H
12   0.60  M/M   M/Mmalton   H
Melting curves results: H, heterozygous Mmalton; N, no Mmalton 
allele.
Figure 4: Results of exonic sequencing of SERPINA1 gene.
(A) Homozygous mutated sample, (B) heterozygous, (C) wild type 
sample.
Little is known about the epidemiology of the non-S 
and non-Z deficient AAT variants, due to their low prev-
alence. A retrospective study performed in Barcelona 
showed that among these variants, PI Mmalton repre-
sented 20% of cases [9]. In the present study, we found 
five PI Mmalton alleles among 12 samples with the MM 
phenotype and low AAT levels. Hence, this allele may 
not be as rare as previously thought. The methodological 
difficulties associated with routine assays are a common 
problem in the study of rare alleles [18]. For this reason, 
it would be of interest to develop standardized studies 
to obtain conclusive data on the prevalence of rare AAT 
variants, such as real-time PCR melting curves, currently 
used in screening programs for the detection of S and Z 
AAT variants. Moreover, this method could be used for 
the study of the most prevalent rare variants in each 
region.
The use of PCR plus DNA sequencing has become an 
essential tool in research and diagnostic laboratories. Nev-
ertheless, this method requires a relatively large amount of 
DNA and involves multiple manual steps, making it labor 
intensive. Moreover, an additional whole blood sample is 
required for exonic sequencing of SERPINA1 gene when 
there is discordance between AAT levels and the IEF phe-
notype pattern. This last fact represents an additional 
invasive blood extraction and a significant delay in AATD 
diagnosis. Therefore, simpler, faster and more automated 
genotyping methods are needed for routine use and popu-
lation screening. These methods must be able to perform 
AATD diagnosis in DBS and in serum samples used by the 
routine AAT level determination and phenotyping.
Real-time PCR is now more rapid, sensitive and repro-
ducible and has a reduced risk of carry-over contamination 
[19]. The combination of PCR technology using real-time 
fluorescence and analysis of differences in the melting 
temperatures of specific probes allows polymorphism 
to be easily detected [20]. Among the different types of 
probes available, the FRET probes are increasingly used in 
many applications involving nucleic acid mutation analy-
sis. This technique is highly sensitive allowing the use of 
DBS specimens as described previously by our group in a 
study of the PI S and PI Z AAT alleles [17]. This approach 
has been reported to be particularly useful for large-scale 
population studies, in which samples from different areas 
are sent to a central laboratory [21]. Blood collection on 
filter paper requires a small amount of sample, is mini-
mally invasive and produces a specimen that is inexpen-
sive to ship and needs no special storage conditions. The 
extremely high sensitivity of this technology, which is 
able to study a very low amount of DNA recovered from 
DBS samples, could potentially allow similar studies in 
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residual DNA which remains in standard clinical serum 
samples [22].
With this objective in mind, the present study reports 
the development of a new qualitative fluorescent real-time 
PCR assay to detect the PI Mmalton AATD allele using spe-
cific FRET probes and DBS specimens and also standard 
serum samples. Homozygous and heterozygous Mmalton 
genotypes can be detected at the same time.
Therefore, this real-time PCR for PI Mmalton genotyp-
ing, together with real-time PCR for the PI S and PI Z vari-
ants, may contribute to the detection of a more complete 
range of AATD variants and determine the real frequency 
of the PI Mmalton variant in different populations [23]. The 
utility of this new technology in serum samples is also a 
very interesting result of our study. In this sense, it should 
be kept in mind that routine AATD studies (AAT levels 
and IEF phenotyping) are performed in serum samples. 
In the case of rare AATD variants not previously correctly 
characterized by these standards studies, further molecu-
lar characterization of these variants requires new EDTA 
whole blood samples and their genotyping by sequencing, 
with the subsequent significant delay in the obtainment 
of results. The results of our study using standard serum 
samples have demonstrated the utility of this new meth-
odology in the molecular characterization of the rare defi-
cient PI Mmalton variant practically within the same time 
as that of standard studies. This represents an important 
improvement of the algorithm for in vitro AATD studies at 
clinical level. In this sense, Snyder et al. [24] reported an 
improved diagnostic algorithm that initially involves AAT 
quantification and allele-specific genotyping, with IEF 
used as a reflex test. In our proposed algorithm, the IEF 
assay is used as the initial technique and allele-specific 
genotyping acts as the reflex technology. Use of IEF before 
genotyping enables detection of some rare AATD alleles 
without the need to design costly allele-specific genotyp-
ing assays. For example, in the Spanish population, there 
is a high frequency of PI I, PI Mmalton, and PI Plowel rare 
AAT variants [9]. The PI I and PI Plowel variants can be 
detected by phenotyping, which is more cost-effective 
than genotyping.
Widespread use of this real-time PCR technology in 
DBS screening and routine AATD studies could demon-
strate the real prevalence of this rare variant, and may 
even allow the clinical characterization of PI Mmalton 
individuals who, to date, are not well characterized.
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